KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 109 filers reported holding KALA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $77,000 | -17.2% | 55,700 | -27.8% | 0.00% | – |
| Q4 2021 | $93,000 | -58.7% | 77,100 | -10.2% | 0.00% | – |
| Q3 2021 | $225,000 | -50.5% | 85,900 | 0.0% | 0.00% | – |
| Q2 2021 | $455,000 | +59.1% | 85,900 | +102.1% | 0.00% | – |
| Q1 2021 | $286,000 | -29.2% | 42,500 | -28.7% | 0.00% | – |
| Q4 2020 | $404,000 | -8.2% | 59,600 | +1.5% | 0.00% | – |
| Q3 2020 | $440,000 | -28.7% | 58,700 | 0.0% | 0.00% | – |
| Q2 2020 | $617,000 | +61.9% | 58,700 | +35.3% | 0.00% | – |
| Q1 2020 | $381,000 | +556.9% | 43,400 | +176.4% | 0.00% | – |
| Q4 2019 | $58,000 | -3.3% | 15,700 | 0.0% | 0.00% | – |
| Q3 2019 | $60,000 | -40.0% | 15,700 | 0.0% | 0.00% | – |
| Q2 2019 | $100,000 | -78.1% | 15,700 | -21.5% | 0.00% | – |
| Q3 2017 | $457,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,333,333 | $5,073,000 | 100.00% |
| CAXTON CORP | 1,483,343 | $5,644,000 | 6.36% |
| Polaris Venture Management Co. V, L.L.C. | 1,197,032 | $4,555,000 | 2.59% |
| RA Capital Management | 4,537,478 | $17,265,000 | 1.03% |
| Orbimed Advisors | 3,447,840 | $13,119,000 | 0.25% |
| Matisse Capital | 46,500 | $177,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 332,831 | $1,266,000 | 0.22% |
| Sofinnova Investments, Inc. | 478,206 | $1,819,000 | 0.16% |
| HARBOURVEST PARTNERS LLC | 99,186 | $377,000 | 0.16% |
| ALGERT GLOBAL LLC | 47,195 | $180,000 | 0.07% |